The global naltrexone market is experiencing exponential growth
driven by rising incidences of autoimmune diseases.
WILMINGTON, Del., July 24, 2024 /PRNewswire/ -- The global
Naltrexone market stood at US$ 21
billion in 2023, and the global market is projected to
reach US$ 30.8 billion in
2034. The Naltrexone market is anticipated to expand at a CAGR
of 3.6% between 2024 and 2034.
The global naltrexone market is witnessing substantial growth,
driven by several key factors. Naltrexone, a medication primarily
used in the treatment of alcohol dependence and opioid addiction,
plays a crucial role in managing substance abuse disorders and
related conditions.
One of the primary drivers of the naltrexone market is the
increasing incidence of substance abuse disorders worldwide. With
growing awareness and recognition of the public health impact of
alcoholism and opioid addiction, healthcare providers are
increasingly prescribing naltrexone to help patients reduce
cravings and maintain sobriety. This has significantly expanded the
market for naltrexone-based therapies.
Moreover, naltrexone's effectiveness in reducing the rewarding
effects of alcohol and opioids contributes to its adoption. By
blocking opioid receptors in the brain, naltrexone helps
individuals break the cycle of addiction and supports long-term
recovery efforts. This mechanism of action has made naltrexone a
cornerstone in medication-assisted treatment (MAT) programs
globally.
Request a PDF Sample of this Report Now!
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=64916
Another key factor driving market growth is the rising
prevalence of autoimmune diseases. Naltrexone has been found to
have immunomodulatory effects, including reducing the inflammatory
response of the immune system towards healthy tissues. This
property has led to its exploration in treating autoimmune
disorders such as multiple sclerosis and Crohn's disease, further
expanding its therapeutic applications and market potential.
The market expansion is also supported by advancements in
pharmaceutical formulations and delivery methods. Extended-release
formulations of naltrexone have improved patient adherence and
convenience, enhancing treatment outcomes for individuals
undergoing MAT or managing chronic conditions.
Furthermore, government initiatives and healthcare policies
aimed at addressing substance abuse and improving access to
addiction treatment services are bolstering market growth.
Increased funding for addiction research and treatment programs
globally has created a conducive environment for the expansion of
naltrexone-based therapies.
Naltrexone Market Report Scope:
Report
Coverage
|
Details
|
Forecast
Period
|
2024-2034
|
Base
Year
|
2020-2022
|
Size in 2023
|
US$ 21.0 Bn
|
Forecast (Value) in
2034
|
US$ 30.8 Bn
|
Growth Rate
(CAGR)
|
3.6 %
|
No. of
Pages
|
123
Pages
|
Segments
covered
|
By Type, By
Application, By Region
|
Key Takeaways of Market Report
- Global Naltrexone market to generate absolute dollar
opportunity worth US$ 30.8 billion
until 2034.
- Global Naltrexone market is valued at US$ 21 billion in 2023.
- North America is forecasted to
hold the largest share in 2023.
Naltrexone Market: Growth Drivers
- According to the National Health Council, autoimmune diseases
are reaching epidemic proportions, with studies suggesting an
annual increase of 3-12%. These conditions arise when the immune
system mistakenly attacks healthy cells, leading to chronic
inflammation and tissue damage. The rising prevalence underscores
the urgent need for effective treatments like naltrexone, which not
only helps manage autoimmune responses but also addresses
associated conditions such as chronic pain and substance abuse
disorders.
- Opioids are a class of potent drugs known for their analgesic
(pain-relieving) and sedative properties. They act on opioid
receptors in the brain and body to alleviate pain and induce a
sense of euphoria. Despite their therapeutic benefits, opioids
carry a high risk of dependence and addiction due to their
addictive properties. Naltrexone plays a crucial role in opioid
addiction treatment by blocking opioid receptors, thereby reducing
cravings and preventing the euphoric effects associated with opioid
use, supporting individuals in achieving and maintaining
sobriety.
Unlock Growth Potential in Your Industry! Download PDF
Brochure:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=64916
Naltrexone Market: Regional Landscape
- North America maintained its
dominance in the naltrexone market in 2023 and is expected to
continue leading through the forecast period. This is driven by
advanced healthcare infrastructure in the
United States and Canada,
supported by robust research and development activities. These
factors enable widespread adoption of naltrexone-based therapies
for treating alcohol dependence, opioid addiction, and other
related disorders.
- Asia Pacific has seen
significant growth in the naltrexone market share, attributed to
increasing awareness campaigns promoted by governmental and
non-governmental organizations. Efforts to combat alcohol and
opioid addictions are driving the demand for naltrexone across the
region, with initiatives aimed at educating healthcare
professionals and the general public about the benefits of using
naltrexone as an antagonist therapy.
Naltrexone Market: Key Players
- In 2023, Sun Pharma focused on expanding its portfolio of
generic naltrexone formulations to cater to the growing demand for
addiction treatment globally. The company strengthened its
manufacturing capabilities and distribution networks to ensure a
reliable supply of naltrexone medications, thereby enhancing
accessibility for patients seeking treatment for alcohol and opioid
dependence.
- In 2023, Sanofi has continued to invest in research and
development initiatives aimed at advancing naltrexone-based
therapies. The company focused on developing novel formulations and
delivery methods for naltrexone, including extended-release
formulations that improve patient compliance and treatment
outcomes.
Naltrexone Market: Segmentation
- Type
-
- Application
-
- Opioid Independence
- Alcohol Independence
- End-user
-
- Hospitals & Clinics
- Rehabilitation Centers
- Wellness Centers
- Others (Research and Academic Institutes, etc.)
- Region
-
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Purchase the Report for Market-Driven Insights:
https://www.transparencymarketresearch.com/checkout.php?rep_id=64916<ype=S
Have a Look at More Valuable Insights of
Pharmaceutical
- Peptide Therapeutics Market: The worldwide market
for peptide therapeutics is forecasted to augment at a CAGR of
8.8% from 2022 to 2031. According to Transparency Market
Research, sales of Peptide Therapeutics are slated to total
USD 91.25 Bn by the end of the
aforementioned period of assessment.
- Cell Culture Market: The global cell culture market
stood at USD 10.5 Bn in 2020
and the global market is projected to reach USD 27.6 Bn by 2031. The global industry is
anticipated to expand at a CAGR of 9.0% between 2021 and
2031.
- Spine Biologics Market - Rise in prevalence of spinal
disorders and increase in geriatric population is driving the
global spine biologics market.
- Gene Vector Market – Market for Gene Vector is
projected to advance at a CAGR of 12.6% from 2022 to 2031 and reach
more than US$ 3.4 Bn by the end of
2031.
About Transparency Market Research
Transparency Market Research, a global market research
company registered at Wilmington,
Delaware, United States,
provides custom research and consulting services. Our exclusive
blend of quantitative forecasting and trends analysis provides
forward-looking insights for thousands of decision makers. Our
experienced team of Analysts, Researchers, and Consultants use
proprietary data sources and various tools & techniques to
gather and analyses information.
Our data repository is continuously updated and revised by a
team of research experts, so that it always reflects the latest
trends and information. With a broad research and analysis
capability, Transparency Market Research employs rigorous primary
and secondary research techniques in developing distinctive data
sets and research material for business reports.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER
DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware
19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free:
866-552-3453
Website: https://www.transparencymarketresearch.com
Email: sales@transparencymarketresearch.com
Follow Us: LinkedIn | Twitter |
Blog | YouTube
Logo:
https://mma.prnewswire.com/media/1682871/TMR_Logo_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/naltrexone-market-surges-to-usd-30-8-billion-by-2034--driven-by-increasing-substance-abuse-awareness-and-treatment-demand--reports-tmr-302205189.html